Genital Diseases, Female  >>  cisplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

31 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cisplatin / Generic mfg.
NCT00003209: Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer

Completed
3
700
Europe
bleomycin sulfate, cisplatin, fluorouracil, ifosfamide, methotrexate, mitomycin C, vinblastine sulfate, vindesine, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC, Medical Research Council
Cervical Cancer
12/99
 
NCT00002493: Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Completed
3
US
cisplatin, doxorubicin hydrochloride, low-LET photon therapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
04/01
 
NCT00006356: Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer

Terminated
3
38
Europe
carboplatin, cisplatin, conventional surgery
European Organisation for Research and Treatment of Cancer - EORTC
Ovarian Cancer
10/02
 
NCT00006096: Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva

Terminated
3
US, Canada
cisplatin, radiation therapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Vulvar Cancer
01/03
 
NCT00002894: Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer

Completed
3
800
Europe
carboplatin, cisplatin, paclitaxel
Medical Research Council
Ovarian Cancer, Primary Peritoneal Cavity Cancer
 
06/03
NCT00057928: S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Withdrawn
3
0
US, Canada
cisplatin, gemcitabine hydrochloride, paclitaxel
Southwest Oncology Group, National Cancer Institute (NCI)
Cervical Cancer
07/03
07/03
NCT00016341: Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Terminated
3
US, Canada
filgrastim, cisplatin, doxorubicin hydrochloride, megestrol acetate, paclitaxel, tamoxifen citrate
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Cancer
10/03
 
NCT00017004: Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Completed
3
114
US
External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam RT, Cisplatin, Internal Radiation Therapy, Brachytherapy, Internal Radiation, Internal Radiation Brachytherapy, Radiation Brachytherapy, Epoetin Alfa, EPO, Epogen, Eprex, erythropoietin, r-HuEPO
Gynecologic Oncology Group, Canadian Cancer Trials Group, National Cancer Institute (NCI)
Anemia, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Drug Toxicity, Radiation Toxicity, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
05/04
 
NCT00003691: Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Completed
3
240
US, Canada
filgrastim, cisplatin, doxorubicin hydrochloride, paclitaxel
Gynecologic Oncology Group, National Cancer Institute (NCI)
Endometrial Cancer
06/04
 
NCT01097252: Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

Completed
3
104
RoW
radiation, weekly cisplatin, Cisplatin, tri-weekly cisplatin
Korea Cancer Center Hospital
Cervical Cancers
12/04
12/09
NCT00054067: Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix

Terminated
3
Japan, US
cisplatin, adjuvant therapy, conventional surgery, brachytherapy, radiation therapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Cancer
04/05
 
NCT00003078: Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix

Completed
3
870
US, Canada
cisplatin, fluorouracil, brachytherapy, radiation therapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Cancer
11/05
 
NCT00003322: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer

Completed
3
384
US, Canada
cisplatin, paclitaxel, quality-of-life assessment
Gynecologic Oncology Group, National Cancer Institute (NCI)
Ovarian Cancer, Primary Peritoneal Cavity Cancer
01/06
 
NCT00003945: Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Completed
3
400
US, RoW
cisplatin, topotecan hydrochloride
Gynecologic Oncology Group, National Cancer Institute (NCI), Eastern Cooperative Oncology Group
Cervical Cancer
01/07
 
NCT00002536: Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer

Completed
3
US
cisplatin, vincristine sulfate, surgical procedure, radiation therapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Cancer
08/07
 
NCT00002717: Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Completed
3
324
US
cisplatin, paclitaxel
Gynecologic Oncology Group, National Cancer Institute (NCI)
Ovarian Cancer, Primary Peritoneal Cavity Cancer
10/07
 
NCT00191100: Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix

Completed
3
515
RoW
Gemcitabine, LY188011, Gemzar, Cisplatin, Brachytherapy, Pelvic radiation
Eli Lilly and Company
Cancer of Cervix
04/08
04/08
NCT00085631: Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer

Terminated
3
101
US
cisplatin, Platinol-AQ, hyperthermia treatment, brachytherapy, external beam radiation therapy
Mark Dewhirst, National Cancer Institute (NCI), Northwestern University
Cervical Cancer
11/08
06/09
NCT00003636: Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer

Completed
3
704
Canada, Europe, RoW
carboplatin, cisplatin, conventional surgery, neoadjuvant therapy
European Organisation for Research and Treatment of Cancer - EORTC
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
01/09
 
NCT00006011: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Completed
3
659
US
Doxorubicin Hydrochloride, Cisplatin, Filgrastim, G-CSF, Nivestim, r-metHuG-CSF, Pegfilgrastim, Filgrastim SD-01, GCSF-SD01, Neulasta, Paclitaxel, Anzatax, TAX
Gynecologic Oncology Group, Eastern Cooperative Oncology Group, National Cancer Institute (NCI)
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer
03/10
 
NCT00122772: CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Completed
3
601
Canada, Europe, RoW
Radiotherapy, Radiotherapy/Cisplatin
International Atomic Energy Agency
Cervix Cancer
06/10
06/10
NCT00005583: Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Completed
3
400
Europe, RoW
cisplatin, doxorubicin hydrochloride, epirubicin hydrochloride, adjuvant therapy, conventional surgery, radiation therapy
Nordic Society of Gynaecological Oncology - Clinical Trials Unit, European Organisation for Research and Treatment of Cancer - EORTC
Endometrial Cancer
 
07/10
NCT00064077: Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Completed
3
513
US
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Quality-of-Life Assessment, Quality of Life Assessment, Topotecan Hydrochloride, Hycamptamine, Hycamtin, SKF S-104864-A, Topotecan HCl, topotecan hydrochloride (oral), Vinorelbine Tartrate, Biovelbin, Eunades, KW-2307, Navelbine, Navelbine Ditartrate, NVB, Vinorelbine Ditartrate
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Carcinoma, Stage IVB Cervical Cancer
01/11
01/18
HOSTT, NCT00921635: A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix

Suspended
3
2
RoW
Blood transfusion
Tri-Service General Hospital, National Taiwan University Hospital
Cervical Cancer, Anemia
05/11
 
NCT00295789: Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

Completed
3
253
Japan
chemotherapy: Paclitaxel/Cisplatin, chemotherapy: Paclitaxel/Carboplatin
Haruhiko Fukuda, Ministry of Health, Labour and Welfare, Japan
Uterine Cervical Neoplasms
11/11
11/11
NCT01461772: Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Terminated
3
21
RoW
Radiation therapy, Carboplatin, Cisplatin
Asan Medical Center, Boryung Pharmaceutical Co., Ltd
Cervical Cancer
05/14
05/14
NCT02083211: Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Completed
3
168
RoW
mAb Nimotuzumab, Placebo
National Institute of Cancerología, Pisa S.A de C.V, National Heart Institute, Mexico
Cervical Cancer Recurrent or Persistent, Palliative Treatment, Monoclonal Antibody in Cervical Cancer Treatment
05/14
06/14
NCT01561586: Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer

Recruiting
3
374
RoW
Weekly cisplatin with RT, Cisplatin, Tri-weekly cisplatin with RT
Korea Cancer Center Hospital, Seoul National University Hospital, Asan Medical Center, Gangnam Severance Hospital
Cervical Cancer
03/20
03/23
NACOPRAD, NCT02422563: NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB

Not yet recruiting
3
534
Europe
hysterectomy, Radiation, Cisplatin, Paclitaxel, Carboplatin, Ifosfamide
Charite University, Berlin, Germany
Cervical Cancer
10/20
10/25
SYSGO-003, NCT02629718: Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer

Recruiting
3
700
RoW
NACT (Paclitaxel + Cisplatin or carboplatin), radical surgery
Sun Yat-sen University
PFS, OS, Quality of Life
12/22
12/22
NCT03071289: A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer

Recruiting
3
540
RoW
Radiation Method B, Cisplatin, Radiation Method A
Sun Yat-sen University
Cervical Cancer, Lymphocyst, Radiation Therapy
03/25
03/25

Download Options